Spotlight Innovation is committed to developing quality-of-life-enhancing biotechnologies that have the potential to positively impact the health, well-being and longevity of an enormous number of lives. We are building a portfolio of bioscience companies, each having the potential to further our commitment.
Celtic Biotech Iowa, Inc.
Celtic Biotech Iowa is developing novel therapeutic products for the treatment of cancers and pain in humans. Derived from naturally specialized receptor-binding proteins, these products have the potential to reduce treatment costs, increase survivability, and improve the quality of life for cancer patients.
Biotechnologies
Memcine Pharmaceuticals, Inc.
Memcine Pharmaceuticals is an early-stage biotech company focused on enhancing vaccine efficacy to improve human and animal health globally. Memcine’s Immunoplex™ technology platform uses the body’s naturally occurring targeting system to deliver vaccine components. The current portfolio of potential infectious disease vaccine targets includes influenza, HepB, and Ebola. Memcine Pharmaceuticals has also conducted pre-clinical experiments in a mouse model of breast cancer, where the vaccine technology showed considerable promise as a therapeutic treatment.
Biotechnology